Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03783325 · ClinicalTrials.gov registry record · NA
Assessing Gene-Environment Interactions in Clinical Presentation of Nevi and Melanoma
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
NCT03783325: Completed NA study, sponsored by University of Colorado, Denver.
NCT03783325 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 71 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03783325, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
Study Summary
This research study is designed to better understand the role of genetics, sun-exposure and phenotypic factors in melanoma.
Primary Outcome
A short questionnaire is administered during the clinic visit to assess sun exposure behaviors of melanoma patients. The data gathered from this questionnaire will help identify possible trends in sun exposure behaviors and provide a baseline dataset for future research,
Interventions
- BEHAVIORAL UV Counseling
- OTHER UV Photo
- OTHER Biological Sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2017-02-17 |
| Est. Completion | 2022-06-17 |
| Phase | NA |
What the finished NCT03783325 record still lists
NCT03783325 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 3 interventions - of which UV Counseling is the first listed.
NCT03783325 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03783325 about?
NCT03783325 is a clinical study titled "Assessing Gene-Environment Interactions in Clinical Presentation of Nevi and Melanoma". This research study is designed to better understand the role of genetics, sun-exposure and phenotypic factors in melanoma.
What is the current status of trial NCT03783325?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2017-02-17. Estimated completion is 2022-06-17.
What interventions are being tested in trial NCT03783325?
The interventions under investigation include: UV Counseling (BEHAVIORAL), UV Photo (OTHER), Biological Sample (OTHER).
Who is sponsoring clinical trial NCT03783325?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03783325's enrollment target sits among peer trials
71 1102nd of 2000 higher than 898 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI